If you find this podcast useful please give it a rating and review on iTunes by clicking here
Do you want to get instant company alerts to the front screen of your smartphone? Download the Vox Markets app here: www.VoxMarkets.co.uk/app
On today's Vox Markets Podcast: Arix Bioscience, Vadim Alexandre on Synairgen and Glen Goodman
Tim Xu, Investment Associate at Arix Bioscience #ARIX talks about one of their portfolio companies, Amplyx Pharmaceuticals, which announced positive topline data from its Phase 2 clinical trial.
Arix Bioscience plc is a global venture capital company focused on investing in and building breakthrough biotech companies around cutting edge advances in life sciences. We collaborate with exceptional entrepreneurs and provide the capital, expertise and global networks to help accelerate their ideas into important new treatments for patients. As a listed company, we are able to bring this exciting growth phase of our industry to a broader range of investors.
Vadim Alexandre, Head of Healthcare at SP Angel discusses Synairgen #SNG
(Interview starts at 9 minutes 56 seconds)
Glen Goodman, former ITV News Business correspondent and now author of, "The Crypto Trader", covers this week’s Bitcoin price action and news.
(Interview starts at 23 minutes 50 seconds)